We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Urology

Journal Scan / Research · May 06, 2014

Sequential BCG and Electromotive Mitomycin for Bladder Cancer



Additional Info

Contemporary Cost-Effectiveness Analysis Comparing Sequential Bacillus Calmette-Guerin and Electromotive Mitomycin Versus Bacillus Calmette-Guerin Alone for Patients With High-Risk Non-Muscle-Invasive Bladder Cancer
Cancer 2014 Apr 18;[EPub Ahead of Print], BG Bachir, A Dragomir, AG Aprikian, S Tanguay, A Fairey, GS Kulkarni, RH Breau, PC Black, W Kassouf

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading